Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study

Anniina Hyväkkä; Okko-Sakari Kääriäinen; Tapio Utriainen; Eliisa Löyttyniemi; Kalle Mattila; Petri Reinikainen; Jorma Sormunen; Minna Jääskeläinen; Päivi Auvinen; Heikki Minn; Maria Sundvall

doi:10.1002/cam4.5262

Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study

Anniina Hyväkkä, Okko-Sakari Kääriäinen, Tapio Utriainen, Eliisa Löyttyniemi, Kalle Mattila, Petri Reinikainen, Jorma Sormunen, Minna Jääskeläinen, Päivi Auvinen, Heikki Minn, Maria Sundvall

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Cancer medicine
Volym	12
Nummer	4
Sidor (från-till)	4064-4076
Antal sidor	13
ISSN	2045-7634
DOI	https://doi.org/10.1002/cam4.5262
Status	Publicerad - feb. 2023
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1002/cam4.5262

Cancer Medicine - 2022 - Hyv kk - Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer inSlutlig publicerad version, 963 KBLicens: CC BY

Citera det här

Hyväkkä, A., Kääriäinen, O.-S., Utriainen, T., Löyttyniemi, E., Mattila, K., Reinikainen, P., Sormunen, J., Jääskeläinen, M., Auvinen, P., Minn, H., & Sundvall, M. (2023). Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study. Cancer medicine , 12(4), 4064-4076. https://doi.org/10.1002/cam4.5262

@article{a018556494b1439bb077eced3c2dc315,

title = "Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study",

keywords = "3122 Cancers, radium-233 (Ra-223) therapy, Bone metastases, Castration-resistant prostate cancer, Real-world evidence",

author = "Anniina Hyv{\"a}kk{\"a} and Okko-Sakari K{\"a}{\"a}ri{\"a}inen and Tapio Utriainen and Eliisa L{\"o}yttyniemi and Kalle Mattila and Petri Reinikainen and Jorma Sormunen and Minna J{\"a}{\"a}skel{\"a}inen and P{\"a}ivi Auvinen and Heikki Minn and Maria Sundvall",

year = "2023",

month = feb,

doi = "10.1002/cam4.5262",

language = "English",

volume = "12",

pages = "4064--4076",

journal = "Cancer medicine ",

issn = "2045-7634",

publisher = "John Wiley and Sons Inc",

number = "4",

}

Hyväkkä, A, Kääriäinen, O-S, Utriainen, T, Löyttyniemi, E, Mattila, K, Reinikainen, P, Sormunen, J, Jääskeläinen, M, Auvinen, P, Minn, H & Sundvall, M 2023, 'Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study', Cancer medicine , vol. 12, nr. 4, s. 4064-4076. https://doi.org/10.1002/cam4.5262

TY - JOUR

T1 - Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland

T2 - A real-world evidence multicenter study

AU - Hyväkkä, Anniina

AU - Kääriäinen, Okko-Sakari

AU - Utriainen, Tapio

AU - Löyttyniemi, Eliisa

AU - Mattila, Kalle

AU - Reinikainen, Petri

AU - Sormunen, Jorma

AU - Jääskeläinen, Minna

AU - Auvinen, Päivi

AU - Minn, Heikki

AU - Sundvall, Maria

PY - 2023/2

Y1 - 2023/2

KW - 3122 Cancers

KW - radium-233 (Ra-223) therapy

KW - Bone metastases

KW - Castration-resistant prostate cancer

KW - Real-world evidence

U2 - 10.1002/cam4.5262

DO - 10.1002/cam4.5262

M3 - Article

SN - 2045-7634

VL - 12

SP - 4064

EP - 4076

JO - Cancer medicine

JF - Cancer medicine

IS - 4

ER -